Valeant Says Insurers Must Defend Allergan, Stock-Drop Suits
By Jeff Sistrunk · January 12, 2018, 9:18 PM EST
Valeant Pharmaceuticals has sued an AIG unit and other insurers, seeking coverage of its costs to defend lawsuits accusing it of orchestrating an insider trading scheme in connection with its attempted...
To view the full article, register now.